Home > Healthcare > Medical Devices > Therapeutic Devices > Cough Assist Devices Market
Cough Assist Devices Market size was valued at over USD 205.1 million in 2022 and is anticipated to grow at a CAGR of over 7.2% between 2023 and 2032. Increasing patient preference towards homecare settings, technological advancements and rising prevalence of respiratory disorders are among the key factors driving the industry growth. The global population is aging, and older adults are more susceptible to respiratory conditions and muscle weakness. The elderly population often requires assistance in maintaining proper lung function and managing respiratory secretions. Cough assist devices offer a non-invasive and effective solution for airway clearance in these individuals, contributing to market expansion.
Further, cough assist devices provide a means for individuals to receive respiratory therapy at home, improving their quality of life and reducing healthcare costs associated with hospital visits. The convenience and comfort offered by home-based cough assist devices are driving market growth. Thus, such aforementioned factors are set to cumulatively drive the cough assist devices market growth in the foreseeable future.
A cough assist device, also known as a mechanical insufflator-exsufflator, is a medical device used to assist individuals with impaired cough function in clearing their airways and managing respiratory secretions. It is primarily used for people with conditions that affect the muscles involved in coughing, such as neuromuscular disorders, spinal cord injuries, or certain respiratory conditions.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cough Assist Devices Market Size in 2022: | USD 205.1 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7.2% |
2032 Value Projection: | USD 419.7 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 359 |
Segments covered: | Product Type, Choice of Delivery, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Cough assist devices can be expensive, especially for individuals without insurance coverage or in regions with limited healthcare resources. The high cost of these devices can act as a barrier to adoption, limiting market growth, particularly in low-income or developing regions. Further, lack of awareness, proper training and education for patients and caregivers on the correct use of the devices can hinder their effectiveness and limit market growth. Additionally, maintenance and servicing of the devices in home settings may pose logistical challenges, potentially impacting their utilization.